Bass Medical Group
Bass Medical Group was paid $18.65M by Medicaid between Jan 2018 and Dec 2024, across 166 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoBASS MEDICAL GROUP
WALNUT CREEK, CA 94598
WALNUT CREEK, CA 94598
33aNPI1154401941assigned 10/16/2006
33bProvider typeSpecialist
28Total paid$18.65M
24GClaims272,586
24DCodes billed166
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#5 of 1,230
Median peer was paid$51K
This provider vs. median363×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,555 | $1.84M | |
| 2019 | 34,863 | $1.96M | |
| 2020 | 33,651 | $1.83M | |
| 2021 | 35,877 | $2.34M | |
| 2022 | 41,793 | $3.29M | |
| 2023 | 52,251 | $3.86M | |
| 2024incomplete | 47,596 | $3.52M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 40,022 | 37,116 | $2.80M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.6% | 41,865 | 39,124 | $1.61M |
| 95144 | 6.6% | 10,948 | 4,361 | $1.23M | |
| 36902 | 4.7% | 2,070 | 2,002 | $881K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.4% | 6,066 | 5,727 | $818K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 4.3% | 12,530 | 5,818 | $808K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 4.2% | 1,082 | 1,080 | $775K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 4.0% | 3,182 | 3,169 | $744K |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | 3.7% | 1,938 | 951 | $696K |
| 93925 | 3.5% | 5,426 | 5,344 | $654K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.5% | 5,978 | 5,960 | $652K |
| 37246 | 3.4% | 486 | 465 | $630K |
154 more codes
| 95811 | 2.9% | 1,091 | $549K | |
| 36475 | 2.9% | 947 | $546K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.6% | 2,676 | $486K |
| 93970 | 2.3% | 5,971 | $425K | |
| 99203 | Doctor's office visit, new patient (routine) | 1.8% | 4,977 | $331K |
| 93990 | 1.7% | 5,269 | $321K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 12,309 | $310K |
| 90961 | 1.1% | 1,118 | $214K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 7,602 | $212K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.0% | 4,790 | $195K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 799 | $184K |
| 99223 | Prolong inpt eval add15 m | <1% | 1,743 | $183K |
| 99205 | Prolong outpt/office vis | <1% | 1,284 | $175K |
| 43775 | <1% | 518 | $146K | |
| 95115 | <1% | 17,177 | $143K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,388 | $139K |
| 93922 | <1% | 2,084 | $112K | |
| 99078 | <1% | 5,857 | $88K | |
| 75710 | <1% | 1,170 | $80K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,698 | $73K |
| 36907 | <1% | 714 | $70K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,511 | $69K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,171 | $64K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 564 | $61K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,695 | $61K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,698 | $54K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 167 | $53K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,208 | $50K |
| 36140 | <1% | 720 | $47K | |
| 31231 | <1% | 244 | $46K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 967 | $45K |
| 52000 | <1% | 220 | $43K | |
| 93971 | <1% | 1,786 | $41K | |
| 36471 | <1% | 1,604 | $39K | |
| 99243 | <1% | 395 | $38K | |
| 94010 | <1% | 1,027 | $38K | |
| 92567 | <1% | 2,818 | $37K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 309 | $35K |
| 99354 | <1% | 279 | $34K | |
| 76937 | <1% | 3,316 | $30K | |
| 92557 | <1% | 1,197 | $29K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 964 | $26K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 488 | $22K |
| 95806 | <1% | 144 | $19K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,594 | $19K |
| 93000 | <1% | 1,020 | $18K | |
| 92552 | <1% | 541 | $18K | |
| 36482 | <1% | 61 | $17K | |
| 92556 | <1% | 444 | $17K | |
| 69210 | <1% | 685 | $17K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 254 | $16K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 213 | $15K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 159 | $14K |
| 76830 | Ultrasound, transvaginal | <1% | 97 | $14K |
| 99490 | Ccm add 20min | <1% | 1,550 | $13K |
| 51741 | <1% | 1,534 | $12K | |
| 76857 | <1% | 554 | $12K | |
| 31575 | <1% | 159 | $11K | |
| 51798 | <1% | 1,667 | $11K | |
| 99188 | <1% | 706 | $11K | |
| 85018 | <1% | 4,651 | $9K | |
| 92588 | <1% | 285 | $8K | |
| 99487 | Ccm add 20min | <1% | 168 | $8K |
| 82947 | <1% | 1,703 | $7K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 157 | $5K |
| 99454 | <1% | 389 | $5K | |
| 99457 | <1% | 384 | $5K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $5K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $4K |
| 90962 | <1% | 36 | $4K | |
| 11056 | <1% | 290 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,470 | $4K |
| 99201 | <1% | 100 | $4K | |
| 11721 | <1% | 302 | $4K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 83 | $3K |
| 92504 | <1% | 131 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 37 | $3K |
| 90674 | <1% | 109 | $3K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 353 | $3K |
| 99439 | <1% | 250 | $3K | |
| 99497 | <1% | 43 | $3K | |
| 81002 | <1% | 936 | $3K | |
| 99072 | <1% | 594 | $3K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 273 | $3K |
| 20610 | <1% | 203 | $3K | |
| 99458 | <1% | 261 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 347 | $2K |
| 59425 | <1% | 110 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 41 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 296 | $2K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 162 | $2K |
| 0012A | <1% | 53 | $2K | |
| 47562 | <1% | 14 | $2K | |
| 0011A | <1% | 57 | $2K | |
| 11750 | <1% | 14 | $2K | |
| 96127 | <1% | 207 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 136 | $2K |
| 93923 | <1% | 12 | $2K | |
| 46600 | <1% | 12 | $1K | |
| 73630 | <1% | 86 | $1K | |
| 90686 | <1% | 1,935 | $1K | |
| 99152 | <1% | 113 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 126 | $1K |
| 95819 | <1% | 25 | $1K | |
| 76942 | <1% | 51 | $1K | |
| 99091 | <1% | 33 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 42 | $938.40 |
| 20611 | <1% | 430 | $864.55 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 37 | $837.89 |
| 20550 | <1% | 13 | $833.23 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 114 | $796.50 |
| 75625 | <1% | 27 | $752.49 | |
| 90756 | <1% | 27 | $598.36 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 439 | $584.85 |
| 95816 | <1% | 12 | $519.14 | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 14 | $492.59 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 14 | $435.52 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 600 | $427.05 |
| 31502 | <1% | 26 | $405.28 | |
| 76000 | <1% | 57 | $382.33 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 15 | $332.80 |
| 0072A | <1% | 12 | $310.00 | |
| 99173 | <1% | 64 | $308.89 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 124 | $300.00 |
| 90651 | <1% | 498 | $297.06 | |
| J3490 | Unclassified drugs | <1% | 58 | $273.72 |
| 87807 | <1% | 30 | $231.39 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 71 | $226.82 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $156.81 |
| 90661 | <1% | 124 | $147.40 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 18 | $130.86 |
| 90715 | <1% | 28 | $34.06 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 13 | $17.49 |
| 92550 | <1% | 24 | $12.55 | |
| 90648 | <1% | 174 | $9.39 | |
| 90723 | <1% | 69 | $9.22 | |
| 90670 | <1% | 74 | $9.16 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 14 | $0.64 |
| 90696 | <1% | 13 | $0.02 | |
| 90633 | <1% | 29 | $0.02 | |
| 90734 | <1% | 151 | $0.02 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 18 | $0.00 |
| 1036F | 0% | 184 | $0.00 | |
| 3074F | 0% | 52 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 15 | $0.00 |
| G8410 | Footwear evaluation performed and documented | 0% | 17 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 103 | $0.00 |
| 97760 | 0% | 17 | $0.00 | |
| 3078F | 0% | 65 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 16 | $0.00 |
| G0127 | Trimming of dystrophic nails, any number | 0% | 12 | $0.00 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 19 | $0.00 |
| 90685 | 0% | 13 | $0.00 | |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNAGESETTY, RAJIV (AUTHORIZED OFFICIAL)